| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
The Journal of Immunology, Vol 140, Issue 9 3040-3044, Copyright © 1988 by American Association of Immunologists
ARTICLES |
GG Wong, JS Witek-Giannotti, PA Temple, R Kriz, C Ferenz, RM Hewick, SC Clark, K Ikebuchi and M Ogawa
Genetics Institute, Inc., Cambridge, MA 02140.
A novel hemopoietic CSF has been identified in the medium conditioned by lectin-stimulated human T cells. The cDNA clone encoding this factor, isolated by functional expression cloning in monkey cos-1 cells, proved to be identical with the cDNA encoding the cytokine B cell stimulatory factor-2/IFN-beta 2, a factor now known as IL-6. In the murine system, IL-6 indirectly supports the formation of several different types of hemopoietic colonies, including those derived from early blast cells, and directly supports the proliferation of granulocyte/macrophage progenitors. These results expand the range of known target cells of IL-6 to include hemopoietic progenitors in addition to B cells, T cells, and fibroblasts and provide further evidence that this cytokine plays an important role within a network of interacting cytokines that regulates many different biologic responses.
This article has been cited by other articles:
|
|
 |
|
  D. Sanocka, P. Jedrzejczak, A. Szumala-Kaekol, M. Fraczek, and M. Kurpisz Male Genital Tract Inflammation: The Role of Selected Interleukins in Regulation of Pro-Oxidant and Antioxidant Enzymatic Substances in Seminal Plasma J Androl, May 1, 2003; 24(3): 448 - 455. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Khaldoyanidi, S. Karakhanova, J. Sleeman, P. Herrlich, and H. Ponta CD44 variant-specific antibodies trigger hemopoiesis by selective release of cytokines from bone marrow macrophages Blood, May 13, 2002; 99(11): 3955 - 3961. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Khaldoyanidi, J. Moll, S. Karakhanova, P. Herrlich, and H. Ponta Hyaluronate-Enhanced Hematopoiesis: Two Different Receptors Trigger the Release of Interleukin-1beta and Interleukin-6 From Bone Marrow Macrophages Blood, August 1, 1999; 94(3): 940 - 949. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N Fortunel, P Batard, A Hatzfeld, M. Monier, B Panterne, J Lebkowski, and J Hatzfeld High proliferative potential-quiescent cells: a working model to study primitive quiescent hematopoietic cells J. Cell Sci., January 7, 1998; 111(13): 1867 - 1875. [Abstract] [PDF]
|
|
|
|
 |
|
 W. M. Murray, J. J. Bruno, M. R. Cahill, I. J. Perry, H. Rus, F. I. Niculescu, P. M. Ridker, C. H. Hennekens, and A. Maseri Inflammation, Aspirin, and the Risk of Cardiovascular Disease N. Engl. J. Med., August 7, 1997; 337(6): 422 - 424. [Full Text]
|
|
|
|
 |
|
 S. P. Hauser, O. Kajkenova, and D. A. Lipschitz The Pivotal Role of Interleukin 6 in Formation and Function of Hematopoietically Active Murine Long-Term Bone Marrow Cultures Stem Cells, March 1, 1997; 15(2): 125 - 132. [Abstract] [Full Text]
|
|
|
|
 |
|
 R. Jilka, G Hangoc, G Girasole, G Passeri, D. Williams, J. Abrams, B Boyce, H Broxmeyer, and S. Manolagas Increased osteoclast development after estrogen loss: mediation by interleukin-6 Science, July 3, 1992; 257(5066): 88 - 91. [Abstract] [PDF]
|
|
|
|
 |
|
 R M Schmitt, E Bruyns, and H R Snodgrass Hematopoietic development of embryonic stem cells in vitro: cytokine and receptor gene expression. Genes & Dev., May 1, 1991; 5(5): 728 - 740. [Abstract] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
